Detalhe da pesquisa
1.
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Cognition in Multiple Sclerosis.
Ann Neurol
; 94(5): 925-932, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496368
2.
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome.
Ann Neurol
; 93(3): 604-614, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401339
3.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242680
4.
Therapeutic lag: Is treatment effect delayed in progressive MS?
Mult Scler
; 30(7): 843-846, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616520
5.
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
Mult Scler
; 30(6): 707-713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456445
6.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Eur J Neurol
; 31(6): e16250, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549186
7.
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Brain
; 146(6): 2489-2501, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515653
8.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171104
9.
Assessing heterogeneity of treatment effect in multiple sclerosis trials.
Mult Scler
; 29(9): 1158-1161, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555493
10.
Enhancing diversity of clinical trial populations in multiple sclerosis.
Mult Scler
; 29(9): 1174-1185, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555490
11.
Enhancing involvement of people with multiple sclerosis in clinical trial design.
Mult Scler
; 29(9): 1162-1173, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555494
12.
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Mult Scler
; 29(11-12): 1363-1372, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691493
13.
Improving the efficiency of clinical trials in multiple sclerosis.
Mult Scler
; 29(9): 1136-1148, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555492
14.
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis.
Eur J Neurol
; 30(12): 3854-3867, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204031
15.
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.
Eur J Neurol
; 30(1): 179-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36168741
16.
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
Eur J Neurol
; 30(8): 2357-2364, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154406
17.
Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials.
Mult Scler
; 28(11): 1744-1751, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581943
18.
Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies.
Mult Scler
; 28(11): 1719-1728, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485424
19.
Estimation of sample size in randomized controlled trials in multiple sclerosis studying annualized relapse rates: A systematic review.
Mult Scler
; 28(9): 1457-1466, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697961
20.
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.
Mult Scler
; 28(1): 111-120, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33969750